Zimmer Biomet Doubling Down on Innovation During COVID

By Mike Evers

Zimmer Biomet Doubling Down on Innovation During COVID
While the company’s orthopedic revenues declined in the high single-digits in 1Q20, Zimmer Biomet’s balance sheet and cost containment measures will allow it to aggressively pursue key R&D initiatives.

Member-Only Content

SUBSCRIBE Login

Tags: Revenue Report